| Meridia (sibutramine) / AbbVie |
| Completed | N/A | 120 | US | Sibutramine, Slim Fast | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Protocol #1:Behavioral Therapy + Placebo or Sibutramine, Protocol #2: Behavioral Therapy + Meal Replacement or Conventional Food | | 08/07 | | |
| Completed | N/A | 436 | US | Sibutramine, Behavioral Smoking Cessation Program | University of Tennessee, National Heart, Lung, and Blood Institute (NHLBI) | Cardiovascular Diseases, Heart Diseases, Obesity | 08/08 | 08/08 | | |
NCT01184560: Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine |
|
|
| Completed | N/A | 174 | RoW | Sibutramine, Orlistat | Gachon University Gil Medical Center | Obesity | 07/10 | 07/10 | | |
AOS, NCT01023139: "Efficacy in Adolescents of Continued Behavior Modification Following a Six Month Sibutramine-based Weight Management Intervention" |
|
|
| Unknown status | N/A | 100 | US | Sibutramine | Brooke Army Medical Center, 59th Medical Wing | Obesity | 11/10 | 03/11 | | |
NCT00829283: Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care |
|
|
| Completed | N/A | 191 | US | Behavioral Weight Loss, Behavioral Weight Loss + Guided self-help Cognitive-behavioral Therapy, Placebo, Sibutramine/Orlistat | Yale University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Obesity, Binge Eating | 11/13 | 11/13 | | |
TOLERASIT, NCT05209997: Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity |
|
|
| Withdrawn | N/A | 1500 | RoW | Source document data collection | Eurofarma Laboratorios S.A. | Overweight, Obesity | 04/25 | 12/25 | | |
